Edition:
United States

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

2.23USD
12:00pm EST
Change (% chg)

$-0.06 (-2.62%)
Prev Close
$2.29
Open
$2.29
Day's High
$2.29
Day's Low
$2.23
Volume
13,789
Avg. Vol
107,340
52-wk High
$50.50
52-wk Low
$2.12

Latest Key Developments (Source: Significant Developments)

Innovate Biopharma Inc - Announces Positive Effect Of Larazotide Acetate On Reducing Intestinal Permeability In A Nash Preclinical Study
Monday, 29 Oct 2018 07:00am EDT 

Oct 29 (Reuters) - Innovate Biopharmaceuticals Inc ::INNOVATE BIOPHARMACEUTICALS INC - ANNOUNCES POSITIVE EFFECT OF LARAZOTIDE ACETATE ON REDUCING INTESTINAL PERMEABILITY IN A NASH PRECLINICAL STUDY.INNOVATE BIOPHARMACEUTICALS INC - TOP LINE RESULTS SHOWED LARAZOTIDE HAVING A SIGNIFICANT EFFECT ON INTESTINAL PERMEABILITY.INNOVATE PHARMA - FURTHER DATA IN COMBINATION WITH APPROVED DRUGS IN DEVELOPMENT FOR NASH LIRAGLUTIDE, OBETICHOLIC ACID EXPECTED IN EARLY 2019.INNOVATE BIOPHARMACEUTICALS INC - INNOVATE INTENDS TO LAUNCH A CLINICAL PROGRAM IN NASH WITH A PHASE 2 TRIAL IN 2019..  Full Article

Innovate Biopharma Inc Files For Offering Of Up To $40 Mln Of Common Stock
Monday, 29 Oct 2018 06:41am EDT 

Oct 29 (Reuters) - Innovate Biopharmaceuticals Inc ::INNOVATE BIOPHARMACEUTICALS INC FILES FOR OFFERING OF UP TO $40.0 MILLION OF COMMON STOCK - SEC FILING.  Full Article

Innovate Biopharmaceuticals Reports Q1 Loss Per Share Of $0.76
Wednesday, 16 May 2018 09:10am EDT 

May 16 (Reuters) - Innovate Biopharmaceuticals Inc ::Q1 LOSS PER SHARE $0.76.AT MARCH 31, 2018, CO HELD $13.0 MILLION IN CASH AND CASH EQUIVALENTS.  Full Article

Monster Digital Terminates License Deal Between Monster Inc, SDJ Technologies
Monday, 4 Dec 2017 03:30pm EST 

Dec 4 (Reuters) - Monster Digital Inc ::MONSTER DIGITAL ANNOUNCES STRATEGIC AND LEGAL DEVELOPMENTS.HAS FORWARDED MONSTER INC A NOTICE OF TERMINATION OF TRADEMARK LICENSE DEAL BETWEEN MONSTER INC, SDJ TECHNOLOGIES.MONSTER DIGITAL SAYS HAS BEEN "DISSATISFIED" WITH ROYALTY RATE UNDER LICENSE DEAL, IN LIGHT OF DECREASING SALES, DEMAND FOR ACTION SPORTS CAMERAS.VOLUNTARY DISMISSAL BY PLAINTIFF IN CONNECTION WITH CLASS ACTION COMPLAINT FILED AGAINST CEO, DAVID H. CLARKE & CERTAIN BOARD MEMBERS.BELIEVES ITS EXISTING SPORTS CAMERA BUSINESS CAN STILL BE "VIABLE" WITHOUT USE OF MONSTER BRAND.HAD TALKS WITH OTHER COMPANIES FOR A MORE COST EFFECTIVE LICENSE UNDER WHICH IT COULD MARKET PRODUCTS SUCH AS ACTION SPORTS CAMERAS.  Full Article

Monster Digital provides update regarding closing date for merger with Innovate Biopharmaceuticals
Wednesday, 29 Nov 2017 08:05pm EST 

Nov 29 (Reuters) - Monster Digital Inc ::MONSTER DIGITAL, INC. PROVIDES UPDATE REGARDING ANTICIPATED CLOSING DATE FOR MERGER WITH INNOVATE BIOPHARMACEUTICALS, INC..MONSTER DIGITAL - CO, INNOVATE BIOPHARMACEUTICALS AGREED TO WORK TOWARDS CLOSING OF REVERSE MERGER BETWEEN CO AND INNOVATE ON OR BEFORE DEC 19, 2017​.‍MONSTER FURTHER ANNOUNCES POSITIVE RESULTS OF FINANCIAL RESTRUCTURING​.  Full Article

MONSTER DIGITAL ANNOUNCES EXTENSION OF OFFERS TO AMEND AND EXERCISE WARRANTS
Friday, 17 Nov 2017 12:00pm EST 

Nov 17 (Reuters) - Monster Digital Inc ::MONSTER DIGITAL INC ANNOUNCES EXTENSION OF OFFERS TO AMEND AND EXERCISE WARRANTS.‍EXTENDED EXPIRATION DATE OF OFFER TO AMEND AND EXERCISE WARRANTS UNTIL 5:00 P.M. PACIFIC TIME ON FRIDAY, NOVEMBER 24, 2017​.  Full Article